Richard Huggins is a Dermatology physician affiliated with Henry Ford Health System. OpenAlex indexes 53 publications with 1,013 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3031 W Grand Blvd
Suite 800, Dermatology
Detroit, MI 482023046
Telephone
313-916-2151Registry record last updated 10 Jul 2012.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year20251 payment
- Avita Medical Americas, LLCProgram year20251 payment
- Avita Medical Americas, LlcProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
35.6%Azole Antifungal16.3%Ketoconazole100%Part D≥51 patientsLincosamide Antibacterial12.4%Clindamycin Phosphate100%Part D≥41 patients+ 3 more classes in this area
Dermatology
20%Corticosteroid14.4%Triamcinolone Acetonide100%Part D≥68 patientsalpha-Hydroxy Acid4.1%Ammonium Lactate100%Part D≥14 patients+ 1 more class in this area
Sensory organs
18.2%Corticosteroid18.2%Hydrocortisone55%Clobetasol Propionate32%Betamethasone Valerate7%Betamethasone Dipropionate7%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Over-the-Counter Product Use Among Individuals with Vitiligo: A Cross-Sectional International Survey
Clinical Drug Investigation
2026 - Autologous cell harvesting device provides repigmentation and improves quality-of-life for patients with stable vitiligo lesions in a large and diverse patient population
Journal of the American Academy of Dermatology
2025 - 62783 Beyond 7 years: Investigating Diagnostic Delay of Hidradenitis Suppurativa at an Urban Tertiary Care Dermatology Clinic
Journal of the American Academy of Dermatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Kalkanis, MD
Henry Ford Health System
Shirish Gadgeel, MD
Henry Ford Health System
Mani Menon, MD
Henry Ford Health System
Marcus Zervos, MD
Henry Ford Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”